Showing 1,021 - 1,040 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant co) OR (significant gap)) decrease ))*', query time: 0.52s Refine Results
  1. 1021
  2. 1022
  3. 1023
  4. 1024
  5. 1025

    Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i> by Jannet A. Tobon Ramos (20855642)

    Published 2025
    “…The seroprevalence did not significantly decrease following DA treatment. These results include all individuals sampled, irrespective of whether they took the medications. …”
  6. 1026

    NIE ELISA results. by Jannet A. Tobon Ramos (20855642)

    Published 2025
    “…<div><p>Background</p><p>Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF instead of diethylcarbamazine/albendazole (DA) in Papua New Guinea (PNG). …”
  7. 1027

    Kato Katz and PCR database 12 months collection. by Jannet A. Tobon Ramos (20855642)

    Published 2025
    “…<div><p>Background</p><p>Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF instead of diethylcarbamazine/albendazole (DA) in Papua New Guinea (PNG). …”
  8. 1028

    Master database baseline, 4 weeks and 1 year. by Jannet A. Tobon Ramos (20855642)

    Published 2025
    “…<div><p>Background</p><p>Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF instead of diethylcarbamazine/albendazole (DA) in Papua New Guinea (PNG). …”
  9. 1029
  10. 1030
  11. 1031
  12. 1032
  13. 1033
  14. 1034
  15. 1035
  16. 1036
  17. 1037

    Flow chart. by Myriam Aïche (22290591)

    Published 2025
    Subjects:
  18. 1038
  19. 1039
  20. 1040